H.Res. 1039 · 118th Congress
Recognizing the significance of Charcot-Marie-Tooth disease and the need for robust funding of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health.
- Stage
- In committee
- Sponsor
- Josh Gottheimer
- Introduced
- 2024-02-29
- Latest action
- 2024-03-08 · Referred to the Subcommittee on Health.
Summary
This resolution recognizes that Charcot-Marie-Tooth (CMT) disease is significant and expresses the sense that CMT should receive robust funding for research. CMT disease is a neurological disorder that causes damage to the peripheral nerves.